-
1
Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy
Published 2025-01-01Subjects: Get full text
Article -
2
Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome
Published 2025-12-01Subjects: “…Dapagliflozin…”
Get full text
Article -
3
-
4
-
5
Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production
Published 2025-12-01Subjects: Get full text
Article -
6
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
Published 2025-01-01Subjects: Get full text
Article -
7
Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report
Published 2025-01-01Subjects: “…Dapagliflozin…”
Get full text
Article -
8
Personalized approach in the management of women with heart failure with preserved ejection fraction and carbohydrate metabolism disorders
Published 2024-12-01Subjects: Get full text
Article -
9
Effects of dapagliflozin on heart rate variability, cardiac function, and short-term prognosis in early-onset post-myocardial infarction heart failure
Published 2025-01-01Subjects: “…dapagliflozin…”
Get full text
Article